Not a great fan of Motley Fool but this is their current summary of broker sentiment.
"Should you buy?
Let’s canvas the views of the experts.
Macquarie retained its outperform rating and $326 share price target after CSL reported its results.
Morgans has held firm with its add rating and an improved share price target of $328.20.
UBS stuck with its buy rating and $340 price target.
Citi maintains its a buy rating on CSL shares with a reduced price target from $340 to $325.
Goldman Sachs maintains a neutral rating and has a $296 price target. It describes CSL as “oversold”.
Goldman says:
We continue to believe the shares look oversold (market-relative P/E has de-rated from 2.7x to 1.7x in the last 10 months, and our TP of $296 implies +9% upside from today’s close)."
Not a great fan of Motley Fool but this is their current summary...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$300.77 |
Change
0.000(0.00%) |
Mkt cap ! $145.3B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | $302.30 | $295.20 | $3.388M | 11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 954 | $321.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $242.11 | 300 | 4 |
View Market Depth
| Last trade - 10.00am 15/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |
Day chart unavailable